Ganciclovir — Membership Pricing
Ganciclovir is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Ganciclovir Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $42.00 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Ganciclovir
Ganciclovir is a prescription medication. Ask your doctor if Ganciclovir is right for you.
How to Check Ganciclovir Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Ganciclovir at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Infections
About Ganciclovir
Ganciclovir is a critical antiviral medication used to treat serious infections caused by Cytomegalovirus (CMV), particularly in those with weakened immune systems. Given its importance and potential high cost, finding affordable access is key. TheDrugClub membership helps you navigate these expenses, providing significant savings on vital prescriptions like ganciclovir.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Ganciclovir is approved for (FDA label)
ZIRGAN is indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older. ZIRGAN is a nucleoside analog antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older. ( 1 )
Source: Read the full FDA label on DailyMed. Label effective date: May 18, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Ganciclovir (FDA label)
Ophthalmic gel: 0.15% ganciclovir. Ophthalmic gel: 0.15% ganciclovir. ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: ea25e7ac-7a93-4ec8-975b-2cec197e1c27. SPL document ID: 52207853-4445-f142-e063-6394a90a281c. Label effective date: May 18, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Ganciclovir (FDA label)
Most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%). Most common adverse reactions were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%). ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated, at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Source: FDA prescribing information (DailyMed). Set ID: ea25e7ac-7a93-4ec8-975b-2cec197e1c27. SPL document ID: 52207853-4445-f142-e063-6394a90a281c. Label effective date: May 18, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Ganciclovir (FDA label)
ZIRGAN is indicated for topical ophthalmic use only. ( 5.1 ) Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with ZIRGAN. ( 5.2 ) 5.1 Topical Ophthalmic Use Only ZIRGAN is indicated for topical ophthalmic use only. 5.2 Avoidance of Contact Lenses Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with ZIRGAN. 5.3 Risk of Contamination Do not allow the tip of the container to touch any surface, as this may contaminate the ointment. If pain develops, or if redness, itching, or inflammation becomes aggravated, the patient should be advised to consult a physician.
Source: FDA prescribing information (DailyMed). Set ID: ea25e7ac-7a93-4ec8-975b-2cec197e1c27. SPL document ID: 52207853-4445-f142-e063-6394a90a281c. Label effective date: May 18, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.